Biotech startup Aerin Medical raised $16.7 million in Series C funding on Tuesday to commercialize in select markets. Targeted Technology Fund led the initial stage with $6.1 million in funding ...

Aerin Medical Inc., which has developed new medical technology for treating common nasal airway conditions, has raised $48 million and named a new chief executive who recently helped lead another ...

January 13, 2025--(BUSINESS WIRE)--Aerin Medical, Inc., ("Aerin" or "the Company") a high-growth medical device company focused on expanding access to meaningful relief for millions of patients ...

--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports ...

SUNNYVALE, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, today announced ...

AUSTIN, Texas, July 31, 2018 /PRNewswire/ -- Aerin Medical, Inc. ("Aerin") announced that over 1,000 patients suffering from nasal obstruction have successfully received the VIVAER ® Nasal Airway ...

SUNNYVALE, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, today announced the ...